Table 1.

Study population characteristics, Survey of Physician Attitudes Regarding the Care of Cancer Survivors (SPARCCS)

		PCPs (N=980)		Oncologists (N=1098)

		N^a	%	N^a	%
Physician characteristics
Age
	< 40 years old	226	22.7	320	30.9
	40–49 years old	324	33.8	293	28.9
	50–59 years old	293	30.4	290	24.7
	60+ years old	137	13.2	195	15.5
Sex
	Female	330	36.1	285	27.2
	Male	650	63.9	813	72.8
Race
	NH White	686	70.9	710	63.1
	Asian	165	15.0	289	28.1
	Other	107	11.7	76	6.9
	Unknown	22	2.3	23	2.0
Income
	Not salaried	353	36.2	266	23.2
	Primarily fee-for-service	388	40.2	465	41.7
	Primarily capitation	134	13.0	118	11.4
	Salaried, not specified	104	10.5	244	23.4
	Unknown	1	0.1	5	0.4
Country of training
	U.S.	725	76.7	739	64.6
	International	255	23.3	359	35.4
Practice characteristics
Volume of breast cancer patients (PCP/Oncologists)
	0–5/year; 0–10/week	238	24.4	343	31.8
	6–15/year; 11–20/week	288	28.9	363	33.1
	16–25/year; 21–30/week	181	19.6	204	17.9
	26+/year; 31+/week	252	25.0	184	16.8
	Unknown	21	2.0	4	0.4
Practice size (number of physicians)
	1	240	23.9	119	10.1
	2–5	408	43.1	422	39.1
	6–100+	316	31.4	538	49.0
	Unknown	16	1.6	19	1.8
Employment arrangement
	Full/Part owner of physician practice	526	54.8	512	45.0
	Employee of physician owned practice	94	10.4	116	11.3
	Employee of large group/HMO	182	17.5	113	10.6
	Employee of university hospital or clinic	62	6.3	234	21.6
	Other	111	10.7	112	10.1
	Unknown	5	0.5	11	1.4
EMR use
	Paper records	373	39.9	241	21.8
	Partial EMR	124	13.2	207	19.0
	In transition from paper	154	14.9	277	24.5
	Full EMR	315	30.8	363	33.4
	Unknown	14	1.3	10	1.3
Proportion of uninsured patients
	0–5%	619	64.1	740	66.7
	6–25%	273	27.4	231	20.6
	26–100%	46	4.5	44	4.2
	Unknown	42	4.0	83	8.5
Teaching hospital affiliation
	Yes	394	41.1	569	51.9
	No	580	58.4	527	48.0
	Unknown	6	0.5	2	0.2
Metropolitan Statistical Area (MSA)
	≥ 1 million	597	61.4	709	65.8
	All other MSAs	383	38.6	389	34.2
Physician attitudes and practices
PCP involvement in breast cancer surveillance testing (PCPs only)
	Not Involved	397	43.0
	Co-manages (shared care)	396	38.6
	Provides	81	17.7
	Unknown	6	0.7
Self-efficacy (confidence in knowledge of breast cancer surveillance testing)
	Not at all confident	55	6.4	5	0.5
	Somewhat confident	506	51.8	157	14.6
	Very confident	413	41.1	935	84.8
	Unknown	6	0.7	1	0.1
Perceived ambiguity about surveillance testing recommendations^b
	Disagree	179	19.2	377	34.6
	Don't know	119	12.5	21	1.9
	Agree	651	65.1	674	61.2
	Unknown	31	3.2	26	2.3
Defensive medicine (test ordering to protect against malpractice litigation)
	Never	133	14.2	202	18.9
	Rarely	317	31.9	445	40.0
	Sometimes	331	33.3	325	29.7
	Often	130	13.3	95	8.6
	Almost Always	25	2.4	11	1.0
	Unknown	44	4.9	20	1.9
Use of breast cancer survivorship care plans
	Never	118	12.0	43	3.9
	Rarely	242	24.6	181	16.4
	Sometimes	249	25.2	275	24.8
	Often	206	21.1	306	27.4
	Almost Always	152	15.8	271	25.0
	Unknown	13	1.4	22	2.4
Role Communication^c
	Mean, SE	3.15	0.04	3.88	0.04

N is the unweighted sample size and percents are weighted to the US population of physicians

Perceived ambiguity = belief in conflicting expert recommendations regarding appropriate management of breast cancer survivors

Role communication = aggregate measure (range 1–5) of self-reported extent of communication with patients and other physicians about which physician will follow patients for their cancer and other health problems

Data source: Survey of Physician Attitudes Regarding the Care of Cancer Survivors (SPARCCS)